Shameer Mehta
Overview
Explore the profile of Shameer Mehta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andreyev J, Adams R, Bornschein J, Chapman M, Chuter D, Darnborough S, et al.
Gut
. 2025 Mar;
PMID: 40068855
Background: Survival rates after a diagnosis of cancer are improving. Poorly managed gastrointestinal (GI) side effects can interfere with delivery of curative cancer treatment. Long-term physical side effects of cancer...
2.
Kumaravel Kanagavelu A, Khani A, Boloorsazmashadi R, Khan R, Langmead L, Mehta S
Cureus
. 2024 Dec;
16(11):e73837.
PMID: 39691112
Ulcerative colitis (UC) is a chronic immune-mediated intestinal condition. This case report describes an 82-year-old woman who was newly diagnosed with UC. Two years prior, she had multiple admissions for...
3.
Patel P, Fragkos K, Keane N, Wilkinson D, Johnson A, Chan D, et al.
Clin Nutr ESPEN
. 2024 Jan;
59:118-125.
PMID: 38220364
Introduction: Variation in access to parenteral nutrition (PN) in patients with intestinal failure secondary to malignant bowel obstruction (MBO) exists due to differing practice, beliefs and resource access. We aimed...
4.
5.
Lewis A, Sanchez S, Berti G, Pan-Castillo B, Nijhuis A, Mehta S, et al.
Clin Sci (Lond)
. 2022 Sep;
136(19):1405-1423.
PMID: 36156078
Intestinal fibrosis and stricture formation is an aggressive complication of Crohns disease (CD), linked to increased morbidity and costs. The present study investigates the contribution of Wingless-Int-1 (Wnt) signalling to...
6.
Miller C, Kwok H, Harrow P, Vega R, Seward E, Mehta S, et al.
Frontline Gastroenterol
. 2022 Sep;
13(5):392-401.
PMID: 36051959
Background: Sequential drug treatment with biological agents in ulcerative colitis (UC) is becoming increasingly complex. There are few studies comparing head-to-head outcomes in second-line treatments. The study assesses whether using...
7.
A retrospective analysis of malnutrition risk, nutritional support and outcomes in COVID-19 patients
Bell J, Heyer N, Greenstein A, Fragkos K, Baxter-Derrington C, Mehta S
Clin Nutr ESPEN
. 2022 Jul;
50:196-206.
PMID: 35871924
Background: The association between obesity and disease severity in COVID-19 has been reported, whilst the impact of undernutrition remains less well-defined. Here we describe nutritional risk profiles of consecutive COVID-19...
8.
Sebastian S, Patel K, Segal J, Subramanian S, Conley T, Gonzalez H, et al.
BMJ Open Gastroenterol
. 2022 Feb;
9(1).
PMID: 35101886
Introduction: Acute severe ulcerative colitis (ASUC) traditionally requires inpatient hospital management for intravenous therapies and/or colectomy. Ambulatory ASUC care has not yet been evaluated in large cohorts. Aims: We used...
9.
Gadhok R, Paulon E, Tai C, Olushola T, Barragry J, Rahman F, et al.
Frontline Gastroenterol
. 2021 Oct;
12(6):471-477.
PMID: 34712464
Objective: Up to 90% of patients treated for pelvic cancers experience chronic gastrointestinal (GI) symptoms. This study characterises this patient cohort at a single centre, addressing a paucity of publications...
10.
Kennedy N, Lin S, Goodhand J, Chanchlani N, Hamilton B, Bewshea C, et al.
Gut
. 2021 Apr;
70(10):1884-1893.
PMID: 33903149
Objective: Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether patients with inflammatory bowel disease treated with...